Inflammation‐Responsive Nanocolloidal Hydrogel Enables On‐Demand Gene Activation for Osteoarthritis Therapy
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.71557 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Yuexin Zhao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Taishan People's Hospital, Postdoctoral Innovation Practice Base of Southern Medical University, Taishan, China. Hauptthemen laut MEDLINE: Osteoarthritis, Nanoparticles, Hydrogels, NF-E2-Related Factor 2. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Medical Science and Technology Foundation of Guangdong Province, Guangdong Provincial Department of Education.
Abstract (Originalsprache)
Synovitis‐driven inflammation and oxidative stress are key drivers of osteoarthritis (OA) progression. As a master regulator of antioxidant and anti‐inflammatory defenses, nuclear factor erythroid 2‐related factor 2 (Nrf2) represents a promising therapeutic target. However, current strategies for Nrf2 activation remain limited in achieving durable synovial gene expression and pathology‐adaptive release. Here, we developed an injectable inflammation‐responsive nanocolloidal hydrogel enabling sustained and on‐demand Nrf2 activation within OA joints. The hydrogel was fabricated by crosslinking polyvinyl alcohol (PVA) with phenylboronic acid (PBA)‐functionalized nanoparticles encapsulating Nrf2 plasmids. Dynamic boronate ester linkages between PBA and PVA enabled rapid in situ gelation after intra‐articular injection. In the ROS‐enriched inflammatory microenvironment of OA, cleavage of boronate ester bonds triggered the release of Nrf2 plasmid‐loaded nanoparticles. The released nanoparticles were efficiently internalized by fibroblast‐like synoviocytes (FLSs) and promoted Nrf2 expression, thereby suppressing oxidative stress and inflammatory responses. In ACLT‐induced OA mice, the hydrogel markedly alleviated synovial inflammation, preserved cartilage matrix, and reduced the OARSI score by approximately 70%. These findings highlight its potential as a promising strategy for inflammation‐adaptive gene regulation in OA therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Taishan People's Hospital, Postdoctoral Innovation Practice Base of Southern Medical University, Taishan, China.
- Division of Orthopaedics and Traumatology, Department of Orthopaedics, Nanfang Hospital, Southern Medical University, Guangzhou, China.
- Huadu District People's Hospital of Guangzhou, Guangzhou, China.
- Department of Clinical Laboratory, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
Förderung
- National Natural Science Foundation of China
- Medical Science and Technology Foundation of Guangdong Province
- Guangdong Provincial Department of Education
- Guangzhou Health Science and Technology General Guidance Project
Zitieren
APA
Zhao, Y., Song, Y., Shen, Y., Chen, K., Yang, X., Chen, Q., Chen, G., & Chen, B. (2026). Inflammation‐Responsive Nanocolloidal Hydrogel Enables On‐Demand Gene Activation for Osteoarthritis Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71557
Vancouver
Zhao Y, Song Y, Shen Y, Chen K, Yang X, Chen Q, et al. Inflammation‐Responsive Nanocolloidal Hydrogel Enables On‐Demand Gene Activation for Osteoarthritis Therapy. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71557
BibTeX
@article{Zhao2026,
author = {Zhao, Yuexin and Song, Yang and Shen, Yuling and Chen, Keyu and Yang, Xin and Chen, Qinghua and Chen, Guo and Chen, Bin},
title = {Inflammation‐Responsive Nanocolloidal Hydrogel Enables On‐Demand Gene Activation for Osteoarthritis Therapy},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.71557}
}
EUVIMED